List of SBIR/STTR awards granted to Leukogene Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Leukogene Therapeutics Inc. in May, 2022 for $671,746.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42CA268138-01 | Phase I | 671,746 | May 17, 2022 | |||||||
A STTR Phase II contract was awarded to Leukogene Therapeutics Inc. in June, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42CA213488-02 | Phase II | 2,000,000 | June 1, 2018 | |||||||
A STTR Phase I contract was awarded to Leukogene Therapeutics Inc. in September, 2021 for $362,118.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA265624-01 | Phase I | 362,118 | September 24, 2021 | |||||||
A SBIR Phase II contract was awarded to Leukogene Therapeutics Inc. in August, 2023 for $782,691.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA268138-02 | Phase II | 782,691 | August 1, 2023 | |||||||
A STTR Phase I contract was awarded to Leukogene Therapeutics Inc. in September, 2016 for $222,958.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA213488-01 | Phase I | 222,958 | September 22, 2016 | |||||||
A STTR Phase I contract was awarded to Leukogene Therapeutics Inc. for $224,701.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA180255-01 | Phase I | 224,701 |
